Fatigue News and Research RSS Feed - Fatigue News and Research

The National MDS Study aims to identify causes, genetic makeup of fatal blood diseases

The National MDS Study aims to identify causes, genetic makeup of fatal blood diseases

The National Myelodysplastic Syndromes Natural History Study is underway, the ECOG-ACRIN Cancer Research Group and its collaborators announced today. [More]
AF-related symptoms and quality of life worse in women

AF-related symptoms and quality of life worse in women

Women with atrial fibrillation experience more severe symptoms, a lower quality of life and a higher risk of stroke than men, but they have better overall survival, US study data show. [More]
Telephone-based intervention helps reduce menopause-related insomnia, hot flashes

Telephone-based intervention helps reduce menopause-related insomnia, hot flashes

Chatting on the phone with a "sleep coach" and keeping a nightly sleep diary significantly improve sleep quality and reduce insomnia in women through all stages of menopause, according to a new study published today in JAMA Internal Medicine. [More]
Investigational drug abemaciclib shows durable clinical activity for variety of cancer types

Investigational drug abemaciclib shows durable clinical activity for variety of cancer types

The investigational anticancer therapeutic abemaciclib, which targets CDK4 and CDK6, showed durable clinical activity when given as continuous single-agent therapy to patients with a variety of cancer types, including breast cancer, non-small cell lung cancer (NSCLC), glioblastoma, and melanoma, according to results from a phase I clinical trial. [More]
Tecentriq drug gets FDA approval to treat urothelial carcinoma

Tecentriq drug gets FDA approval to treat urothelial carcinoma

The U.S. Food and Drug Administration today approved Tecentriq (atezolizumab) to treat the most common type of bladder cancer, called urothelial carcinoma. This is the first product in its class (PD-1/PD-L1 inhibitors) approved to treat this type of cancer. [More]
Wyss Institute partners with ReWalk to accelerate development of wearable, soft exosuits

Wyss Institute partners with ReWalk to accelerate development of wearable, soft exosuits

The Wyss Institute for Biologically Inspired Engineering at Harvard University has entered into a collaboration with ReWalk Robotics Ltd., to accelerate the development of the Institute's lightweight, wearable soft exosuit technologies for assisting people with lower limb disabilities. [More]
Study finds greater activation of biological fight or flight mechanism in chronic fatigue syndrome patients

Study finds greater activation of biological fight or flight mechanism in chronic fatigue syndrome patients

Chronic fatigue syndrome patients report they are more anxious and distressed than people who don't have the condition, and they are also more likely to suppress those emotions. [More]
Phase 2 results of AbbVie’s venetoclax in patients with R/R CLL with 17p deletion published in The Lancet Oncology

Phase 2 results of AbbVie’s venetoclax in patients with R/R CLL with 17p deletion published in The Lancet Oncology

AbbVie, a global biopharmaceutical company, today announced The Lancet Oncology published results from the Phase 2, single arm, open label trial studying venetoclax in patients with relapsed/refractory (R/R) chronic lymphocytic leukaemia (CLL) with 17p deletion. [More]
Experimental hepatitis C drug slows down development of Zika in mice

Experimental hepatitis C drug slows down development of Zika in mice

Virologists from KU Leuven, Belgium, have shown that an experimental antiviral drug against hepatitis C slows down the development of Zika in mice. The research team was led by Professor Johan Neyts from the Laboratory of Virology and Chemotherapy. [More]
Pluristem completes enrollment in Phase II intermittent claudication trial

Pluristem completes enrollment in Phase II intermittent claudication trial

Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced it has completed the planned enrollment of 150 patients in a global Phase II trial of its PLacental eXpanded (PLX)-PAD cells for the treatment of intermittent claudication (IC), a peripheral artery disease (PAD). The double blind, randomized, placebo controlled trial enrolled 50 patients since October 2015 in the U.S., Germany, Israel, and South Korea. [More]
New national survey reveals that asthma patients most frequently use rescue inhaler

New national survey reveals that asthma patients most frequently use rescue inhaler

In a new national survey of asthma patients, Health Union, and its new online community Asthma.net, reveals that most were satisfied with the care they received; however, the most frequently used form of treatment, at 89%, is the rescue inhaler. [More]

Thermo Scientific Niton XL5 analyzer can provide results rapidly and with high accuracy

Managers, operators and quality control personnel in the oil and gas, power generation, automotive, aerospace and metal recycling industries can now assess the chemical composition of metals with a new analyzer that is smaller and lighter than any X-ray fluorescence (XRF) alloy analyzer on the market today. [More]
Griffith researchers closer to identifying cause of Chronic Fatigue Syndrome

Griffith researchers closer to identifying cause of Chronic Fatigue Syndrome

New findings regarding the pathology of Chronic Fatigue Syndrome (CFS) are bringing Griffith University researchers closer to identifying the cause of this disabling illness. [More]
Sheffield Hallam University lecturer to discuss research into cause of fibromyalgia at parliamentary event

Sheffield Hallam University lecturer to discuss research into cause of fibromyalgia at parliamentary event

A Sheffield Hallam University lecturer will address the Health Secretary and other MPs tomorrow at a parliamentary event that aims to raise awareness of the incurable chronic pain condition, fibromyalgia. [More]
Innovative inflatable footbaths can help you nod off easily during hot sticky nights

Innovative inflatable footbaths can help you nod off easily during hot sticky nights

As temperatures continue to soar this week sleeping on these hot sticky nights can become an issue, so how do we best ensure a successful slumber? [More]
Study shows risk of developing MDD depends on symptom centrality in network

Study shows risk of developing MDD depends on symptom centrality in network

A novel study published in the current issue of Psychotherapy and Psychosomatics discloses how depression may develop. [More]
Promising specialty medical home approach to patient-centered, cost-effective care for IBD patients

Promising specialty medical home approach to patient-centered, cost-effective care for IBD patients

A specialty medical home--providing expert medical care coordinated with attention to social support and mental health--is a promising new approach to patient-centered, cost-effective care for patients with Crohn's disease and ulcerative colitis, according to a special "Future Directions" paper in the May issue of Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America. The journal is published by Wolters Kluwer. [More]
Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Bayer has announced that a Phase III trial evaluating its oncology compound Stivarga® (regorafenib) tablets for the treatment of patients with unresectable hepatocellular carcinoma (HCC) has met its primary endpoint of a statistically significant improvement in overall survival. The study, called RESORCE, evaluated the efficacy and safety of regorafenib in patients with HCC whose disease has progressed after treatment with sorafenib. The safety and tolerability were generally consistent with the known profile of regorafenib. Detailed efficacy and safety analyses from this study are expected to be presented at an upcoming scientific congress. [More]
Yoga, aquatic exercise have positive influence on multiple sclerosis symptoms

Yoga, aquatic exercise have positive influence on multiple sclerosis symptoms

Exercise can have a positive influence on certain symptoms of multiple sclerosis: Patients who do yoga and aquatic exercise suffer less from fatigue, depression and paresthesia, as reported by researchers from the University of Basel and the Psychiatric University Clinics Basel in a joint study with colleagues in Iran. [More]
UGA researcher works to advance effective treatment for infectious mononucleosis

UGA researcher works to advance effective treatment for infectious mononucleosis

The University of Georgia's Mark Ebell wasn't impressed with research on infectious mononucleosis when he wrote his first published review on it back in the 1990s. He still isn't—a subject he discusses in the April issue of the Journal of the American Medical Association. [More]
Advertisement
Advertisement